title: Nucleoside Analogue Triphosphates Allosterically Regulate Human Ribonucleotide Reductase and Identify Chemical Determinants That Drive Substrate Specificity.
abstract: Class I ribonucleotide reductase (RR) maintains balanced pools of deoxyribonucleotide substrates for DNA replication by converting ribonucleoside diphosphates (NDPs) to 2'-deoxyribonucleoside diphosphates (dNDPs). Binding of deoxynucleoside triphosphate (dNTP) effectors (ATP/dATP, dGTP, and dTTP) modulates the specificity of class I RR for CDP, UDP, ADP, and GDP substrates. Crystal structures of bacterial and eukaryotic RRs show that dNTP effectors and NDP substrates bind on either side of a flexible nine-amino acid loop (loop 2). Interactions with the effector nucleobase alter loop 2 geometry, resulting in changes in specificity among the four NDP substrates of RR. However, the functional groups proposed to drive specificity remain untested. Here, we use deoxynucleoside analogue triphosphates to determine the nucleobase functional groups that drive human RR (hRR) specificity. The results demonstrate that the 5-methyl, O4, and N3 groups of dTTP contribute to specificity for GDP. The O6 and protonated N1 of dGTP direct specificity for ADP. In contrast, the unprotonated N1 of adenosine is the primary determinant of ATP/dATP-directed specificity for CDP. Structural models from X-ray crystallography of eukaryotic RR suggest that the side chain of D287 in loop 2 is involved in binding of dGTP and dTTP, but not dATP/ATP. This feature is consistent with experimental results showing that a D287A mutant of hRR is deficient in allosteric regulation by dGTP and dTTP, but not ATP/dATP. Together, these data define the effector functional groups that are the drivers of human RR specificity and provide constraints for evaluating models of allosteric regulation.
authors.affiliation: Departments of Biochemistry, ‡Pharmacology, and §Chemistry, Case Western Reserve University , Cleveland, Ohio 44106, United States.
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Knappenberger
authors.affiliation: Departments of Biochemistry, ‡Pharmacology, and §Chemistry, Case Western Reserve University , Cleveland, Ohio 44106, United States.
authors.forename: Md Faiz
authors.initials: MF
authors.lastname: Ahmad
authors.affiliation: Departments of Biochemistry, ‡Pharmacology, and §Chemistry, Case Western Reserve University , Cleveland, Ohio 44106, United States.
authors.forename: Rajesh
authors.initials: R
authors.lastname: Viswanathan
authors.affiliation: Departments of Biochemistry, ‡Pharmacology, and §Chemistry, Case Western Reserve University , Cleveland, Ohio 44106, United States.
authors.forename: Chris G
authors.initials: CG
authors.lastname: Dealwis
authors.affiliation: Departments of Biochemistry, ‡Pharmacology, and §Chemistry, Case Western Reserve University , Cleveland, Ohio 44106, United States.
authors.forename: Michael E
authors.initials: ME
authors.lastname: Harris
mesh_terms: D000494:Allosteric Regulation; D018360:Crystallography, X-Ray; D006801:Humans; D007700:Kinetics; D016297:Mutagenesis, Site-Directed; D009705:Nucleosides / Q000737:chemistry / Q000378:metabolism*; D011487:Protein Conformation; D012264:Ribonucleotide Reductases / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D013379:Substrate Specificity
chemical_list: D009705:Nucleosides; D012264:Ribonucleotide Reductases